Influence of Vitamin D Status and the VDR Gene Polymorphism on COVID-19 Susceptibility and Outcome Article Swipe
Amal Ahmed Mohamed
,
Nivin Baiomy
,
Abeer M. Rawy
,
Mona M F Ganem
,
Soha M. Abd El Salam
,
Karima Nasraldin
,
Mohamed Ramadan Ezz Al Arab
,
Hussein H. Samir
,
Omar Mohamoud Azzam
,
Nashwa M. Muharram
,
Naglaa Elsalway
,
Ahmed Y. Elamir
,
Sarya Swed
,
Wael Hafez
,
Luis Andrés Salas-Matta
,
Alfonso J. Rodríguez‐Morales
,
D. Katterine Bonilla‐Aldana
,
Hashem Abu Serhan
,
Sanjit Sah
,
Rachana Mehta
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.22207/jpam.18.4.41
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.22207/jpam.18.4.41
Insufficient vitamin D levels in the bloodstream, together with the presence of specific genetic variations known as single nucleotide polymorphisms (SNPs) within the VDR gene, have consistently been linked to a higher likelihood of contracting and experiencing more severe forms of various diseases such as the ongoing COVID-19 pandemic. We aimed to explore the potential relationship between vitamin D levels, Bsml and FOKI polymorphisms, and COVID-19 infection outcomes. A case-control study was conducted with COVID-19 patients and a control group of non-COVID-19 patients (n = 107 each). The associations between vitamin D status, polymorphisms, and COVID susceptibility were investigated. Participants diagnosed with COVID-19 exhibited an average age of 48.84 ± 12.18, while non-COVID-19 patients had an average age of 46.82 ± 9.903. Disease severity, assessed by the CT severity score, showed a negative correlation with the Vitamin D levels. Among participants with COVID-19, the mean level of vitamin D was 35.25 ± 9.40 ng/mL while non-COVID-19 patients showed 38.85 ± 9.40 ng/mL with a significant difference (p = 0.004**) although among COVID-19 cases, 87 (81.3%) individuals had sufficient vitamin D levels and non-severity of disease was more common i.e. 54 (50.5%) among the COVID patients who had sufficient level of Vitamin D. The study found no significant association between Vitamin D levels and rs1544410 Bsml polymorphism (p = 0.429). However, it is important to highlight a weak significant association observed between with Fok1 polymorphism (p = 0.049). These findings underscore the weak influence of genetic factors, particularly VDR Fok1 gene variants, in shaping an individual’s susceptibility to COVID-19. A significant difference in vitamin D status was observed between the COVID-19 and non-COVID-19 groups and lower level was observed in the COVID-19 infected patients. Furthermore, a weak significant association was observed between Fok1 rs2228570 genotype and COVID-19 susceptibility. Larger sample sizes are required to comprehensively understand the association between different genotypes and COVID-19 outcomes.
Related Topics
Concepts
Calcitriol receptor
Coronavirus disease 2019 (COVID-19)
Vitamin D and neurology
Polymorphism (computer science)
Gene polymorphism
2019-20 coronavirus outbreak
Gene
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Vitamin
Biology
Genetics
Internal medicine
Medicine
Virology
Genotype
Disease
Infectious disease (medical specialty)
Outbreak
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.22207/jpam.18.4.41
- OA Status
- gold
- Cited By
- 1
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404741941
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404741941Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.22207/jpam.18.4.41Digital Object Identifier
- Title
-
Influence of Vitamin D Status and the VDR Gene Polymorphism on COVID-19 Susceptibility and OutcomeWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-11-26Full publication date if available
- Authors
-
Amal Ahmed Mohamed, Nivin Baiomy, Abeer M. Rawy, Mona M F Ganem, Soha M. Abd El Salam, Karima Nasraldin, Mohamed Ramadan Ezz Al Arab, Hussein H. Samir, Omar Mohamoud Azzam, Nashwa M. Muharram, Naglaa Elsalway, Ahmed Y. Elamir, Sarya Swed, Wael Hafez, Luis Andrés Salas-Matta, Alfonso J. Rodríguez‐Morales, D. Katterine Bonilla‐Aldana, Hashem Abu Serhan, Sanjit Sah, Rachana MehtaList of authors in order
- Landing page
-
https://doi.org/10.22207/jpam.18.4.41Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.22207/jpam.18.4.41Direct OA link when available
- Concepts
-
Calcitriol receptor, Coronavirus disease 2019 (COVID-19), Vitamin D and neurology, Polymorphism (computer science), Gene polymorphism, 2019-20 coronavirus outbreak, Gene, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Vitamin, Biology, Genetics, Internal medicine, Medicine, Virology, Genotype, Disease, Infectious disease (medical specialty), OutbreakTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404741941 |
|---|---|
| doi | https://doi.org/10.22207/jpam.18.4.41 |
| ids.doi | https://doi.org/10.22207/jpam.18.4.41 |
| ids.openalex | https://openalex.org/W4404741941 |
| fwci | 0.91580991 |
| type | article |
| title | Influence of Vitamin D Status and the VDR Gene Polymorphism on COVID-19 Susceptibility and Outcome |
| biblio.issue | 4 |
| biblio.volume | 18 |
| biblio.last_page | 2702 |
| biblio.first_page | 2688 |
| topics[0].id | https://openalex.org/T10277 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9944000244140625 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Vitamin D Research Studies |
| is_xpac | False |
| apc_list.value | 500 |
| apc_list.currency | USD |
| apc_list.value_usd | 500 |
| apc_paid.value | 500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 500 |
| concepts[0].id | https://openalex.org/C179639408 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8032093644142151 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q417057 |
| concepts[0].display_name | Calcitriol receptor |
| concepts[1].id | https://openalex.org/C3008058167 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7660692930221558 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[1].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[2].id | https://openalex.org/C124490489 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6168285608291626 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7936963 |
| concepts[2].display_name | Vitamin D and neurology |
| concepts[3].id | https://openalex.org/C149737253 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5431668758392334 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3240252 |
| concepts[3].display_name | Polymorphism (computer science) |
| concepts[4].id | https://openalex.org/C76252995 |
| concepts[4].level | 4 |
| concepts[4].score | 0.4794398844242096 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3395645 |
| concepts[4].display_name | Gene polymorphism |
| concepts[5].id | https://openalex.org/C3006700255 |
| concepts[5].level | 3 |
| concepts[5].score | 0.46920982003211975 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[5].display_name | 2019-20 coronavirus outbreak |
| concepts[6].id | https://openalex.org/C104317684 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4435462951660156 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[6].display_name | Gene |
| concepts[7].id | https://openalex.org/C3007834351 |
| concepts[7].level | 5 |
| concepts[7].score | 0.4343453049659729 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[8].id | https://openalex.org/C2776940978 |
| concepts[8].level | 2 |
| concepts[8].score | 0.42828595638275146 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q34956 |
| concepts[8].display_name | Vitamin |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.37775516510009766 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C54355233 |
| concepts[10].level | 1 |
| concepts[10].score | 0.36020833253860474 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[10].display_name | Genetics |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.34969061613082886 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C71924100 |
| concepts[12].level | 0 |
| concepts[12].score | 0.32717204093933105 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[12].display_name | Medicine |
| concepts[13].id | https://openalex.org/C159047783 |
| concepts[13].level | 1 |
| concepts[13].score | 0.2882487177848816 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[13].display_name | Virology |
| concepts[14].id | https://openalex.org/C135763542 |
| concepts[14].level | 3 |
| concepts[14].score | 0.18441757559776306 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q106016 |
| concepts[14].display_name | Genotype |
| concepts[15].id | https://openalex.org/C2779134260 |
| concepts[15].level | 2 |
| concepts[15].score | 0.10055986046791077 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[15].display_name | Disease |
| concepts[16].id | https://openalex.org/C524204448 |
| concepts[16].level | 3 |
| concepts[16].score | 0.07869955897331238 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[16].display_name | Infectious disease (medical specialty) |
| concepts[17].id | https://openalex.org/C116675565 |
| concepts[17].level | 2 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[17].display_name | Outbreak |
| keywords[0].id | https://openalex.org/keywords/calcitriol-receptor |
| keywords[0].score | 0.8032093644142151 |
| keywords[0].display_name | Calcitriol receptor |
| keywords[1].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[1].score | 0.7660692930221558 |
| keywords[1].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[2].id | https://openalex.org/keywords/vitamin-d-and-neurology |
| keywords[2].score | 0.6168285608291626 |
| keywords[2].display_name | Vitamin D and neurology |
| keywords[3].id | https://openalex.org/keywords/polymorphism |
| keywords[3].score | 0.5431668758392334 |
| keywords[3].display_name | Polymorphism (computer science) |
| keywords[4].id | https://openalex.org/keywords/gene-polymorphism |
| keywords[4].score | 0.4794398844242096 |
| keywords[4].display_name | Gene polymorphism |
| keywords[5].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[5].score | 0.46920982003211975 |
| keywords[5].display_name | 2019-20 coronavirus outbreak |
| keywords[6].id | https://openalex.org/keywords/gene |
| keywords[6].score | 0.4435462951660156 |
| keywords[6].display_name | Gene |
| keywords[7].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[7].score | 0.4343453049659729 |
| keywords[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[8].id | https://openalex.org/keywords/vitamin |
| keywords[8].score | 0.42828595638275146 |
| keywords[8].display_name | Vitamin |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.37775516510009766 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/genetics |
| keywords[10].score | 0.36020833253860474 |
| keywords[10].display_name | Genetics |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.34969061613082886 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/medicine |
| keywords[12].score | 0.32717204093933105 |
| keywords[12].display_name | Medicine |
| keywords[13].id | https://openalex.org/keywords/virology |
| keywords[13].score | 0.2882487177848816 |
| keywords[13].display_name | Virology |
| keywords[14].id | https://openalex.org/keywords/genotype |
| keywords[14].score | 0.18441757559776306 |
| keywords[14].display_name | Genotype |
| keywords[15].id | https://openalex.org/keywords/disease |
| keywords[15].score | 0.10055986046791077 |
| keywords[15].display_name | Disease |
| keywords[16].id | https://openalex.org/keywords/infectious-disease |
| keywords[16].score | 0.07869955897331238 |
| keywords[16].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.22207/jpam.18.4.41 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2476582842 |
| locations[0].source.issn | 0973-7510, 2581-690X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0973-7510 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Pure and Applied Microbiology |
| locations[0].source.host_organization | https://openalex.org/P4353108566 |
| locations[0].source.host_organization_name | Dr. M.N. Khan |
| locations[0].source.host_organization_lineage | https://openalex.org/P4353108566 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Pure and Applied Microbiology |
| locations[0].landing_page_url | https://doi.org/10.22207/jpam.18.4.41 |
| locations[1].id | pmh:oai:doaj.org/article:2255640956374f4b901a9df55dcb68d1 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Journal of Pure and Applied Microbiology, Vol 18, Iss 4, Pp 2688-2702 (2024) |
| locations[1].landing_page_url | https://doi.org/10.22207/JPAM.18.4.41 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5080558452 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2014-2239 |
| authorships[0].author.display_name | Amal Ahmed Mohamed |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Amal Ahmed Mohamed |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5027063725 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5215-8673 |
| authorships[1].author.display_name | Nivin Baiomy |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nivin Naeem Baiomy |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5111410684 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Abeer M. Rawy |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Abeer M. Rawy |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5080466299 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4189-8809 |
| authorships[3].author.display_name | Mona M F Ganem |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mona M.F. Ghanem |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5002504479 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Soha M. Abd El Salam |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Soha M. Abd El Salam |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5021526329 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5927-2057 |
| authorships[5].author.display_name | Karima Nasraldin |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Karima Nasraldin |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5111195443 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Mohamed Ramadan Ezz Al Arab |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mohamed Ramadan Ezz Al Arab |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5113204164 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Hussein H. Samir |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Hussein H. Samir |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5101383216 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Omar Mohamoud Azzam |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Omar Mohamoud Azzam |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5056533101 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Nashwa M. Muharram |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Nashwa M. Muharram |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5114357988 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Naglaa Elsalway |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Naglaa Elsalway |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5108320254 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Ahmed Y. Elamir |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ahmed Y. Elamir |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5064001236 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-9983-2020 |
| authorships[12].author.display_name | Sarya Swed |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Sarya Swed |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5054456648 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-1203-0808 |
| authorships[13].author.display_name | Wael Hafez |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Wael Hafez |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5088389641 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6028-7432 |
| authorships[14].author.display_name | Luis Andrés Salas-Matta |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Luis A. Salas-Matta |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5033642008 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-9773-2192 |
| authorships[15].author.display_name | Alfonso J. Rodríguez‐Morales |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Alfonso J. Rodriguez-Morales |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5039063087 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-9412-2556 |
| authorships[16].author.display_name | D. Katterine Bonilla‐Aldana |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | D. Katterine Bonilla-Aldana |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5072111465 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-2953-2188 |
| authorships[17].author.display_name | Hashem Abu Serhan |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Hashem Abu Serhan |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5112857706 |
| authorships[18].author.orcid | https://orcid.org/0009-0008-5017-083X |
| authorships[18].author.display_name | Sanjit Sah |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sanjit Sah |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5027624113 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-4771-4089 |
| authorships[19].author.display_name | Rachana Mehta |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Rachana Mehta |
| authorships[19].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.22207/jpam.18.4.41 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Influence of Vitamin D Status and the VDR Gene Polymorphism on COVID-19 Susceptibility and Outcome |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10277 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9944000244140625 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Vitamin D Research Studies |
| related_works | https://openalex.org/W2408256745, https://openalex.org/W4210971708, https://openalex.org/W4313248744, https://openalex.org/W3213271120, https://openalex.org/W4388704108, https://openalex.org/W4213238068, https://openalex.org/W2121080036, https://openalex.org/W2115434474, https://openalex.org/W2145190142, https://openalex.org/W2586923735 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.22207/jpam.18.4.41 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2476582842 |
| best_oa_location.source.issn | 0973-7510, 2581-690X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0973-7510 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Pure and Applied Microbiology |
| best_oa_location.source.host_organization | https://openalex.org/P4353108566 |
| best_oa_location.source.host_organization_name | Dr. M.N. Khan |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4353108566 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Pure and Applied Microbiology |
| best_oa_location.landing_page_url | https://doi.org/10.22207/jpam.18.4.41 |
| primary_location.id | doi:10.22207/jpam.18.4.41 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2476582842 |
| primary_location.source.issn | 0973-7510, 2581-690X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0973-7510 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Pure and Applied Microbiology |
| primary_location.source.host_organization | https://openalex.org/P4353108566 |
| primary_location.source.host_organization_name | Dr. M.N. Khan |
| primary_location.source.host_organization_lineage | https://openalex.org/P4353108566 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Pure and Applied Microbiology |
| primary_location.landing_page_url | https://doi.org/10.22207/jpam.18.4.41 |
| publication_date | 2024-11-26 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3037812632, https://openalex.org/W4286880263, https://openalex.org/W3022793320, https://openalex.org/W3209200988, https://openalex.org/W3039068365, https://openalex.org/W3204219308, https://openalex.org/W3193755684, https://openalex.org/W3014807714, https://openalex.org/W3014405676, https://openalex.org/W3009912996, https://openalex.org/W1969887669, https://openalex.org/W2992402686, https://openalex.org/W3137394994, https://openalex.org/W2088966225, https://openalex.org/W2166648728, https://openalex.org/W3188097332, https://openalex.org/W3036639325, https://openalex.org/W2588906490, https://openalex.org/W2136619797, https://openalex.org/W3044007210, https://openalex.org/W3086048794, https://openalex.org/W3049206462, https://openalex.org/W3086826118, https://openalex.org/W3187564100, https://openalex.org/W3209316504, https://openalex.org/W3023510226, https://openalex.org/W2061171498, https://openalex.org/W3202770353, https://openalex.org/W4286500386, https://openalex.org/W3171283371, https://openalex.org/W4200592257, https://openalex.org/W4311539113, https://openalex.org/W4380992486, https://openalex.org/W3172480825, https://openalex.org/W2159550537, https://openalex.org/W2107520088, https://openalex.org/W3021837810, https://openalex.org/W2616730536, https://openalex.org/W2103076955, https://openalex.org/W4205634874, https://openalex.org/W3167054662, https://openalex.org/W3187936287, https://openalex.org/W4401649779, https://openalex.org/W3202713826, https://openalex.org/W4205611471, https://openalex.org/W3019037097, https://openalex.org/W2961326123, https://openalex.org/W3205951788, https://openalex.org/W3141223771, https://openalex.org/W2887952286 |
| referenced_works_count | 50 |
| abstract_inverted_index.= | 84, 167, 217, 235 |
| abstract_inverted_index.A | 68, 258 |
| abstract_inverted_index.D | 2, 58, 91, 137, 148, 179, 210, 263 |
| abstract_inverted_index.a | 30, 77, 131, 163, 225, 284 |
| abstract_inverted_index.(n | 83 |
| abstract_inverted_index.(p | 166, 216, 234 |
| abstract_inverted_index.54 | 189 |
| abstract_inverted_index.87 | 173 |
| abstract_inverted_index.CT | 127 |
| abstract_inverted_index.D. | 201 |
| abstract_inverted_index.We | 49 |
| abstract_inverted_index.an | 104, 115, 253 |
| abstract_inverted_index.as | 16, 44 |
| abstract_inverted_index.by | 125 |
| abstract_inverted_index.in | 4, 251, 261, 278 |
| abstract_inverted_index.is | 221 |
| abstract_inverted_index.it | 220 |
| abstract_inverted_index.no | 205 |
| abstract_inverted_index.of | 11, 33, 40, 80, 107, 118, 146, 183, 199, 243 |
| abstract_inverted_index.to | 29, 51, 223, 256, 302 |
| abstract_inverted_index.± | 109, 120, 151, 159 |
| abstract_inverted_index.107 | 85 |
| abstract_inverted_index.The | 87, 202 |
| abstract_inverted_index.VDR | 23, 247 |
| abstract_inverted_index.age | 106, 117 |
| abstract_inverted_index.and | 35, 61, 64, 76, 94, 181, 212, 270, 273, 294, 310 |
| abstract_inverted_index.are | 300 |
| abstract_inverted_index.had | 114, 176, 196 |
| abstract_inverted_index.the | 5, 9, 22, 45, 53, 126, 135, 143, 192, 240, 268, 279, 305 |
| abstract_inverted_index.was | 71, 149, 185, 265, 276, 288 |
| abstract_inverted_index.who | 195 |
| abstract_inverted_index.9.40 | 152, 160 |
| abstract_inverted_index.Bsml | 60, 214 |
| abstract_inverted_index.FOKI | 62 |
| abstract_inverted_index.Fok1 | 232, 248, 291 |
| abstract_inverted_index.been | 27 |
| abstract_inverted_index.gene | 249 |
| abstract_inverted_index.have | 25 |
| abstract_inverted_index.i.e. | 188 |
| abstract_inverted_index.mean | 144 |
| abstract_inverted_index.more | 37, 186 |
| abstract_inverted_index.such | 43 |
| abstract_inverted_index.weak | 226, 241, 285 |
| abstract_inverted_index.were | 97 |
| abstract_inverted_index.with | 8, 73, 101, 134, 141, 162, 231 |
| abstract_inverted_index.35.25 | 150 |
| abstract_inverted_index.38.85 | 158 |
| abstract_inverted_index.46.82 | 119 |
| abstract_inverted_index.48.84 | 108 |
| abstract_inverted_index.Among | 139 |
| abstract_inverted_index.COVID | 95, 193 |
| abstract_inverted_index.These | 237 |
| abstract_inverted_index.aimed | 50 |
| abstract_inverted_index.among | 170, 191 |
| abstract_inverted_index.forms | 39 |
| abstract_inverted_index.found | 204 |
| abstract_inverted_index.gene, | 24 |
| abstract_inverted_index.group | 79 |
| abstract_inverted_index.known | 15 |
| abstract_inverted_index.level | 145, 198, 275 |
| abstract_inverted_index.lower | 274 |
| abstract_inverted_index.ng/mL | 153, 161 |
| abstract_inverted_index.sizes | 299 |
| abstract_inverted_index.study | 70, 203 |
| abstract_inverted_index.while | 111, 154 |
| abstract_inverted_index.(SNPs) | 20 |
| abstract_inverted_index.12.18, | 110 |
| abstract_inverted_index.9.903. | 121 |
| abstract_inverted_index.Larger | 297 |
| abstract_inverted_index.cases, | 172 |
| abstract_inverted_index.common | 187 |
| abstract_inverted_index.each). | 86 |
| abstract_inverted_index.groups | 272 |
| abstract_inverted_index.higher | 31 |
| abstract_inverted_index.levels | 3, 180, 211 |
| abstract_inverted_index.linked | 28 |
| abstract_inverted_index.sample | 298 |
| abstract_inverted_index.score, | 129 |
| abstract_inverted_index.severe | 38 |
| abstract_inverted_index.showed | 130, 157 |
| abstract_inverted_index.single | 17 |
| abstract_inverted_index.status | 264 |
| abstract_inverted_index.within | 21 |
| abstract_inverted_index.(50.5%) | 190 |
| abstract_inverted_index.(81.3%) | 174 |
| abstract_inverted_index.0.049). | 236 |
| abstract_inverted_index.0.429). | 218 |
| abstract_inverted_index.Disease | 122 |
| abstract_inverted_index.Vitamin | 136, 200, 209 |
| abstract_inverted_index.average | 105, 116 |
| abstract_inverted_index.between | 56, 89, 208, 230, 267, 290, 307 |
| abstract_inverted_index.control | 78 |
| abstract_inverted_index.disease | 184 |
| abstract_inverted_index.explore | 52 |
| abstract_inverted_index.genetic | 13, 244 |
| abstract_inverted_index.levels, | 59 |
| abstract_inverted_index.levels. | 138 |
| abstract_inverted_index.ongoing | 46 |
| abstract_inverted_index.shaping | 252 |
| abstract_inverted_index.status, | 92 |
| abstract_inverted_index.various | 41 |
| abstract_inverted_index.vitamin | 1, 57, 90, 147, 178, 262 |
| abstract_inverted_index.0.004**) | 168 |
| abstract_inverted_index.COVID-19 | 47, 65, 74, 102, 171, 269, 280, 295, 311 |
| abstract_inverted_index.However, | 219 |
| abstract_inverted_index.although | 169 |
| abstract_inverted_index.assessed | 124 |
| abstract_inverted_index.diseases | 42 |
| abstract_inverted_index.factors, | 245 |
| abstract_inverted_index.findings | 238 |
| abstract_inverted_index.genotype | 293 |
| abstract_inverted_index.infected | 281 |
| abstract_inverted_index.negative | 132 |
| abstract_inverted_index.observed | 229, 266, 277, 289 |
| abstract_inverted_index.patients | 75, 82, 113, 156, 194 |
| abstract_inverted_index.presence | 10 |
| abstract_inverted_index.required | 301 |
| abstract_inverted_index.severity | 128 |
| abstract_inverted_index.specific | 12 |
| abstract_inverted_index.together | 7 |
| abstract_inverted_index.COVID-19, | 142 |
| abstract_inverted_index.COVID-19. | 257 |
| abstract_inverted_index.conducted | 72 |
| abstract_inverted_index.diagnosed | 100 |
| abstract_inverted_index.different | 308 |
| abstract_inverted_index.exhibited | 103 |
| abstract_inverted_index.genotypes | 309 |
| abstract_inverted_index.highlight | 224 |
| abstract_inverted_index.important | 222 |
| abstract_inverted_index.infection | 66 |
| abstract_inverted_index.influence | 242 |
| abstract_inverted_index.outcomes. | 67, 312 |
| abstract_inverted_index.pandemic. | 48 |
| abstract_inverted_index.patients. | 282 |
| abstract_inverted_index.potential | 54 |
| abstract_inverted_index.rs1544410 | 213 |
| abstract_inverted_index.rs2228570 | 292 |
| abstract_inverted_index.severity, | 123 |
| abstract_inverted_index.variants, | 250 |
| abstract_inverted_index.difference | 165, 260 |
| abstract_inverted_index.likelihood | 32 |
| abstract_inverted_index.nucleotide | 18 |
| abstract_inverted_index.sufficient | 177, 197 |
| abstract_inverted_index.underscore | 239 |
| abstract_inverted_index.understand | 304 |
| abstract_inverted_index.variations | 14 |
| abstract_inverted_index.association | 207, 228, 287, 306 |
| abstract_inverted_index.contracting | 34 |
| abstract_inverted_index.correlation | 133 |
| abstract_inverted_index.individuals | 175 |
| abstract_inverted_index.significant | 164, 206, 227, 259, 286 |
| abstract_inverted_index.Furthermore, | 283 |
| abstract_inverted_index.Insufficient | 0 |
| abstract_inverted_index.Participants | 99 |
| abstract_inverted_index.associations | 88 |
| abstract_inverted_index.bloodstream, | 6 |
| abstract_inverted_index.case-control | 69 |
| abstract_inverted_index.consistently | 26 |
| abstract_inverted_index.experiencing | 36 |
| abstract_inverted_index.non-COVID-19 | 81, 112, 155, 271 |
| abstract_inverted_index.non-severity | 182 |
| abstract_inverted_index.participants | 140 |
| abstract_inverted_index.particularly | 246 |
| abstract_inverted_index.polymorphism | 215, 233 |
| abstract_inverted_index.relationship | 55 |
| abstract_inverted_index.investigated. | 98 |
| abstract_inverted_index.polymorphisms | 19 |
| abstract_inverted_index.individual’s | 254 |
| abstract_inverted_index.polymorphisms, | 63, 93 |
| abstract_inverted_index.susceptibility | 96, 255 |
| abstract_inverted_index.comprehensively | 303 |
| abstract_inverted_index.susceptibility. | 296 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.71688039 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |